![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Leukemia |
Free Subscription
2 Acta Haematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Prognostic Factors, FLT-3 Mutations, and Treatment Outcomes with pediatric
inspired protocols in adolescent and young adults (AYA) and adult patients with
Acute Lymphoblastic Leukemia.
Acta Haematol. 2025 Jan 30:1-24. doi: 10.1159/000543861.
PubMed
Abstract available
Real-World Experience in the Management of Chronic Myeloid Leukemia Patients
Focused on Tyrosine Kinase Inhibitors Intolerance and Health-Related Quality of
Life.
Acta Haematol. 2025 Jan 10:1-14. doi: 10.1159/000542562.
PubMed
Abstract available
Trends and Disparities in Acute Lymphoblastic Leukemia-Related Mortality in the
United States from 1999 to 2020: Insights From the Centers for Disease Control
and Prevention Wide-Ranging Online Data for Epidemiologic Research Database.
Am J Clin Oncol. 2025 Jan 31. doi: 10.1097/COC.0000000000001162.
PubMed
Abstract available
Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at
Diagnosis of Chronic Myeloid Leukemia.
Am J Hematol. 2025 Jan 28. doi: 10.1002/ajh.27608.
PubMed
Abstract available
Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis,
Diagnosis, and Therapy.
Am J Hematol. 2025 Jan 28. doi: 10.1002/ajh.27546.
PubMed
Abstract available
Chromoanagenesis Is Frequently Associated With Highly Complex Karyotypes,
Extensive Clonal Heterogeneity, and Treatment Refractoriness in Acute Myeloid
Leukemia.
Am J Hematol. 2025 Jan 27. doi: 10.1002/ajh.27575.
PubMed
Abstract available
Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for
Automated Fully Standardized Minimal Residual Disease Detection in Chronic
Lymphocytic Leukemia.
Am J Hematol. 2025 Jan 25. doi: 10.1002/ajh.27604.
PubMed
Acute myeloid leukemia with t(8;21) translocation: Molecular pathogenesis,
potential therapeutics and future directions.
Biochem Pharmacol. 2025;233:116774.
PubMed
Abstract available
c-MYC stain as a potential minimal residual disease marker for acute myeloid
leukemia with NPM1 mutation.
Blood. 2025;145:547.
PubMed
IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput
drug screening.
Blood. 2025 Jan 27:blood.2024027171. doi: 10.1182/blood.2024027171.
PubMed
Abstract available
The Fit Older Adult with Acute Myeloid Leukemia: Clinical Challenges to Providing
Evidence-Based Frontline Treatment.
Blood. 2025 Jan 24:blood.2024026004. doi: 10.1182/blood.2024026004.
PubMed
Abstract available
Dynamics of neoantigen-specific T-cells in post-transplant relapse: do leukemia
neoantigens elicit immune responses in transplant recipients?
Bone Marrow Transplant. 2025 Jan 29. doi: 10.1038/s41409-025-02515.
PubMed
Patient-reported outcomes in Chinese patients with chronic myeloid leukemia
receiving olverembatinib: Quality of life matters!
Cancer. 2025;131:e35737.
PubMed
Atovaquone and selinexor as a novel combination treatment option in acute myeloid
leukemia.
Cancer Lett. 2025;613:217501.
PubMed
Abstract available
Central Nervous System Involvement in Chronic Lymphocytic Leukemia: A
Case-Series.
Eur J Haematol. 2025 Jan 31. doi: 10.1111/ejh.14389.
PubMed
The common murine retroviral integration site activating Hhex marks a distal
regulatory enhancer co-opted in human Early T-cell precursor leukemia.
J Biol Chem. 2025 Jan 27:108233. doi: 10.1016/j.jbc.2025.108233.
PubMed
Abstract available
An SH3-binding allosteric modulator stabilizes the global conformation of the
AML-associated Src-family kinase, Hck.
J Biol Chem. 2025;301:108088.
PubMed
Abstract available
Effective eradication of acute myeloid leukemia stem cells with FLT3-directed
antibody-drug conjugates.
Leukemia. 2025 Jan 27. doi: 10.1038/s41375-024-02510.
PubMed
Abstract available
Maternal weight during pregnancy and risk of childhood acute lymphoblastic
leukemia in offspring.
Leukemia. 2025 Jan 26. doi: 10.1038/s41375-025-02517.
PubMed
Abstract available
[Corrigendum] ND?09 inhibits chronic myeloid leukemia K562 cell growth by
regulating BCR?ABL signaling.
Oncol Rep. 2025;53:37.
PubMed
Abstract available
Evaluation of the practical application of the category-imbalanced myeloid cell
classification model.
PLoS One. 2025;20:e0313277.
PubMed
Abstract available
Neomorphic leukemia-derived mutations in the TET2 enzyme induce genome
instability via a substrate shift from 5-methylcytosine to thymine.
Proc Natl Acad Sci U S A. 2025;122:e2418318122.
PubMed
Abstract available
Thank you for your interest in scientific medicine.